New York City, NY -- (SBWIRE) -- 12/24/2013 -- StockMarketIntel.com issues a special report on the following stocks: LVMH Moet Hennessy Louis Vuitton SA(ADR) (OTCMKTS:LVMUY), Vapor Corp., (OTCMKTS:VPCO), Bayer AG (ADR) (OTCMKTS:BAYRY), Titan Pharmaceuticals, Inc. (OTCBB:TTNP).
LVMH Moet Hennessy Louis Vuitton SA(ADR) (OTCMKTS:LVMUY) ended its recent business day with the advanced of 0.51% and closed at the price of $35.69 after opening at $35.27. The stock traded during its last trading session with the total volume of 117.149 shares, as compared to its average volume of 112.454 shares. LVMH Moët Hennessy - Louis Vuitton SA engages in the manufacture and sale of luxury products.
Will LVMUY Continue To Move Higher? Find out via this report
Vapor Corp., (OTCMKTS:VPCO) remained among the day bearish -3.51% and traded with volume of 1.74 million shares in the last session, as compared to average volume of 922.844shares. In comparison with 52 week range of $0.20 - $2.00, it faced lowest price of $1.41 during the last trading session whereas its day highest price was $1.72. The company’s total market capitalization is $99.61 million, along with 60.37 million shares outstanding. Vapor Corp. designs, markets, and distributes electronic cigarettes and accessories primarily in the United States and Canada.
Why Should Investors Buy VPCO After the Recent Fall? Just Go Here and Find Out
Bayer AG (ADR) (OTCMKTS:BAYRY) showed 39.545 shares in volume during the last trading session, while the average trading volume remained 29.552 shares. The stock kicked off its trading session at $137.81 and closed at $139.07 after rallied 2.18%. Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide.
Why Should Investors Buy BAYRY After The Recent Gain? Just Go Here and Find Out
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) stock traded during its last trading session with the total traded volume of 2.18 million shares versus its average volume of 277.698 shares. The company opened its trade at the price of $0.67 and its closing price was $0.637 after fell -12.70% for the day. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia.
Has TTNP Found The Bottom and Ready To Move Up? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)